Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00172835
Status:
UNKNOWN
Last Update Posted:
2005-09-15
First Post:
2005-09-12
Brief Title:
Use of Procalcitonin in the Diagnosis of Pleural Effusion
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Evaluation of Procalcitonin as a Diagnostic Tool for Patients With Pleural Effusion
Status:
UNKNOWN
Status Verified Date:
2005-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Among several markers of inflammation and sepsis procalcitonin PCT markers is being studied to investigate their accuracy for the diagnosis of bacterial infections PCT is the prehormone of calcitonin which is normally secreted by the C cells of the thyroid in response to hypercalcemia under these normal conditions negligible serumPCT concentrations are detected The mechanism proposed for PCT production after inflammation and its role are still not completely known It is believed that PCT is produced by the liver and peripheral blood mononuclear cells modulated by lipopolysaccharides and sepsis-related cytokines It binds to polysaccharides in pathogens activating the classical complement pathway The reported diagnostic accuracy of PCT for the diagnosis of bacterial infections has varied across studies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None